Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: A cross-sectional study

BMJ Open

Volumn 3, Issue 6, 2013, Pages 1-11

  Eritsyan, Ksenia ^a,b   Heimer, Robert ^c   Barbour, Russell ^c   Odinokova, Veronika ^a   White, Edward ^c   Rusakova, Maia M ^a   Smolskaya, Tatiana T ^d   Levina, Olga S ^a  

^a NGO Stellit   (Russian Federation)

^b ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^c YALE UNIVERSITY   (United States)

^d Northwest Regional AIDS Center   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; EPHEDRINE; METHAMPHETAMINE; OPIATE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DRUG USE; ENZYME IMMUNOASSAY; EXPERIENCE; FEMALE; HARM REDUCTION; HEALTH DISPARITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERVIEW; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; QUESTIONNAIRE; RISK; RUSSIAN FEDERATION; SEROLOGY; SEXUAL BEHAVIOR; SOCIAL NETWORK;

EID: 84880411450     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002645     Document Type: Article

References (50)

1. UNAIDS. The changing HIV/AIDS epidemic in Europe and Central Asia. Geneva, Switzerland: UNAIDS, 2004.
2. UNAIDS. UNAIDS Report on the Global AIDS Epidemic. Geneva, Switzerland: UNAIDS, 2010.
3. Federal AIDS Center. Number of registered HIV-positive among Russian citizens on 31.12.2011, 2012.
4. Goliusov AT, Dementyeva LA, Ladnaya NN, et al. Country Progress Report of the Russian Federation on the Implementation of the Declaration of Commitment on HIV/AIDS. Moscow: Federal Service for Surveillance of Consumer Rights Protection and Human Well-Being of the Russian Federation, 2008.
5. National Research Narcology Center. Main indicators of narcology services in the Russian Federation in 2008-2009. Moscow, RF: National Research Narcology Center, 2010.
6. Human Rights Watch. Rehabilitation required: Russia's human rights obligation to provide evidence-based drug dependence treatment. New York, USA: Human Rights Watch, 2007.
7. UN Office on Drugs and Crime. World drug report, 2009. Vienna, Austria: UNODC, 2009.
8. Wingfield-Hayes R. The heroin epidemic advancing on Russia. BBC Radio 2010.
9. Niccolai LM, Toussova OV, Verevochkin SV, et al. High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav 2010;14:932-41.
10. Rhodes T, Lowndes C, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS 2002;16:F25-31.
11. Rhodes T, Platt L, Maximova S, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction 2006;101:252-66. (Pubitemid 43351599)
12. Chen CY, Lin KM. Health consequences of illegal drug use. Curr Opin Psychiatry 2009;22:287-92.
13. Lelutiu-Weinberger C, Pouget ER, Des Jarlais DD, et al. A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Soc Sci Med 2009;68:579-90.
14. Thomson BJ. Hepatitis C virus: the growing challenge. Br Med Bull 2009;89:153-67.
15. Paintsil E, Verevochkin SV, Dukhovlinova E, et al. Hepatitis C virus infection among drug injectors in St. Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction 2009;104:1881-90.
16. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007;18:352-8. (Pubitemid 47374507)
17. Dehne KL, Khodakevich L, Hamers FF, et al. The HIV/AIDS epidemic in eastern Europe: recent patterns and trends and their implication for policy making. AIDS 1999;13:741-9. (Pubitemid 29224575)
18. Heimer R, Booth RE, Irwin KS, et al. In: Twigg JL, ed. HIV/AIDS in Russia and Eurasia. Basingstoke, Hampshire, UK: Palgrave Macmillan, 2007.
19. Rhodes T, Sarang A, Bobrik A, et al. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Int J Drug Policy 2004;15:1-16. (Pubitemid 38115914)
20. Sergeyev B, Oparina T, Rumyantseva TP, et al. HIV Prevention for drug injectors in Yaroslavl, Russia: a peer-driven intervention and needle exchange. J Drug Issues 1999;29:777-804. (Pubitemid 30044116)
21. Heimer R, Kinzly ML, He H, et al. The effect of acids on the survival of HIV during drug injection. J AIDS 2007:144-50. (Pubitemid 46869806)
22. UN Office on Drugs and Crime. World Drug Report, 2004. Vienna, Austria: UNODC, 2004.
23. Paoli L. The development of an illegal market. Drug consumption and trade in post-Soviet Russia. Br J Criminol 2002;42:21-39. (Pubitemid 37449763)
24. Niccolai LM, Shcherbakova IS, Toussova OV, et al. The potential for bridging of HIV transmission in Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health 2009;86(Suppl 1):131-43.
25. Platt L, Rhodes T, Hickman M, et al. Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence. J AIDS 2008;47:623-31. (Pubitemid 351442019)
26. Shaboltas AV, Toussova OV, Hoffman IF, et al. HIV prevalence, socio-demographic and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr 2006;41:657-63.
27. Heckathorn DD. Respondent-driven sampling; a new approach to the study of hidden populations. Soc Probl 1997;44:174-99.
28. Heckathorn DD, Semaan S, Broadhead RS, et al. Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18-25. AIDS Behav 2002;6:55-67. (Pubitemid 35303722)
29. Heckathorn D. Respondent driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl 2002;49:11-34.
30. Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol 2004;34:193-240.
31. Volz E, Heckathorn DD. Probability based estimation theory for respondent-driven sampling. J Official Stat 2008;24:79-97.
32. Family Health International. Behavioral surveillance surveys: guidelines for repeated behavioral surveys in populations at risk of HIV. Arlington, VA, 2000.
33. Ronnegard L, Shen X, Alam M. hglm: a package for fitting hierarchical generalized linear models. R J 2010;2:20-8.
34. De P, Cox J, Boivin J, et al. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction 2007;102:1730-9. (Pubitemid 47573057)
35. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med 1994;38:67-78.
36. Abdala N, Grund J-PC, Tolstov Y, et al. Can homemade injectable opiates contribute to the HIV epidemic among injection drug users in the countries of the former Soviet Union? Addiction 2006;101:731-7.
37. Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. Int J Drug Policy 2009;20:277-82.
38. Ciccarone D, Bourgois P. Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse 2003;38:2049-63. (Pubitemid 37499738)
39. Clatts MC, Heimer R, Abdala N, et al. Illicit drug injection and HIV-1 transmission: heating drug solutions may inactive HIV-1. J Aquir Immune Defic Syndr 1999;22:194-9.
40. de la Fuente L, Saavedra P, Barrio G, et al. Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Drug Alcohol Depend 1996;40:185-94. (Pubitemid 26131381)
41. Avants SK, Warburton LA, Hawkins KA, et al. Continuation of high-risk behavior by HIV-positive drug users. Treatment implications. J Subst Abuse Treat 2000;19:15-22. (Pubitemid 30386991)
42. Fisher JD, Fisher WA. Changing AIDS risk behavior. Psychol Bull 1992;111:455-74.
43. Prochaska JO, Redding CA, Harlow LL, et al. The transtheoretical model of change and HIV prevention: a review. Health Educ Q 1992;21:471-86.
44. Burrows D, Sarang A. Mixed signals: responses to HIV/AIDS in the Russian Federation. Washington, DC: The World Bank, 2004.
45. Sarang A, Stuikyte R, Bykov R. Implementation of harm reduction in Central and Eastern Europe and Central Asia. Int J Drug Policy 2007;18:129-35. (Pubitemid 46413736)
46. Torban MN, Heimer R, Ilyuk RD, et al. Practices and attitudes of addiction treatment providers in the Russian Federation. J Addict Res Ther 2011;2.
47. Csete J. Lessons not learned: human rights abuses and HIV/AIDS in the Russian Federation. Hum Rights Watch 2004;16:1-62.
48. Fedorova EV, Skochilov RV, Heimer R, et al. Access to syringes for HIV prevention for injection drug user in St. Petersburg, Russia: syringe purchase test study. BMC Public Health 2013;epub ahead of print:13:183.
49. Sarang A, Rhodes T, Sheon N, et al. Policing drug users in Russia: risk, fear, and structural violence. Subst Use Misuse 2010; 45:813-64.
50. Sarang A, T R, Platt L. Access to syringes in three Russian cities: implications for syringe distribution and coverage. Int J Drug Policy 2008;19(Suppl 1):25-36.